
1. arch virol. 2012 oct;157(10):1971-4. epub 2012 jun 19.

17-allylamino-17-(demethoxy)geldanamycin (17-aag) potent effective
inhibitor human cytomegalovirus replication primary fibroblast cells.

evers dl(1), chao cf, zhang z, huang es.

author information: 
(1)lineberger comprehensive cancer center, university north carolina chapel
hill, chapel hill, nc 27599, usa. eversdl@comcast.net

the 90 % human cytomegalovirus inhibitory concentration of
17-allylamino-17-(demethoxy)geldanamycin (17-aag) 0.1 nm 50 %
cytotoxicity required least 10 μm concentration. three molecular targets may
explain antiviral activities compound. (1) heat shock
protein maturation complexes, (2) host cell cycle progression (3)
phosphatidylinositol 3-kinase signaling. however, data suggested mechanism 
of action 17-aag blocked immediate-early protein transactivation.

doi: 10.1007/s00705-012-1379-7 
pmid: 22711259  [indexed medline]

